Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 33 | 2016 | 390 | 3.150 |
Why?
|
| Brain Concussion | 20 | 2022 | 60 | 2.520 |
Why?
|
| Schizophrenia | 20 | 2016 | 38 | 2.340 |
Why?
|
| Neuropsychological Tests | 45 | 2020 | 379 | 2.330 |
Why?
|
| Schizophrenic Psychology | 12 | 2012 | 15 | 1.300 |
Why?
|
| Brain Injuries | 16 | 2015 | 94 | 1.240 |
Why?
|
| Magnetic Resonance Imaging | 37 | 2016 | 1221 | 1.120 |
Why?
|
| Athletic Injuries | 11 | 2020 | 77 | 1.110 |
Why?
|
| Brain | 23 | 2018 | 930 | 1.110 |
Why?
|
| Awareness | 5 | 2009 | 29 | 0.880 |
Why?
|
| Hippocampus | 9 | 2015 | 185 | 0.820 |
Why?
|
| Memory | 17 | 2018 | 187 | 0.810 |
Why?
|
| Frontal Lobe | 13 | 2010 | 45 | 0.800 |
Why?
|
| Alzheimer Disease | 12 | 2012 | 312 | 0.750 |
Why?
|
| Memory Disorders | 11 | 2016 | 61 | 0.740 |
Why?
|
| Hockey | 9 | 2015 | 11 | 0.730 |
Why?
|
| Image Processing, Computer-Assisted | 13 | 2018 | 242 | 0.720 |
Why?
|
| Adult | 61 | 2022 | 8484 | 0.700 |
Why?
|
| Male | 80 | 2020 | 17896 | 0.680 |
Why?
|
| Humans | 104 | 2022 | 29293 | 0.670 |
Why?
|
| Female | 78 | 2020 | 18270 | 0.660 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2018 | 53 | 0.600 |
Why?
|
| Psychiatric Status Rating Scales | 12 | 2016 | 93 | 0.600 |
Why?
|
| Cognition | 8 | 2017 | 526 | 0.560 |
Why?
|
| Mental Disorders | 4 | 2013 | 111 | 0.540 |
Why?
|
| Geriatric Assessment | 2 | 2008 | 356 | 0.530 |
Why?
|
| Problem Solving | 7 | 2011 | 28 | 0.520 |
Why?
|
| Diffusion Tensor Imaging | 6 | 2020 | 29 | 0.510 |
Why?
|
| Amnesia | 3 | 2010 | 10 | 0.500 |
Why?
|
| Psychometrics | 4 | 2016 | 129 | 0.480 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2018 | 43 | 0.450 |
Why?
|
| Young Adult | 20 | 2022 | 2415 | 0.440 |
Why?
|
| Adolescent | 20 | 2022 | 3267 | 0.410 |
Why?
|
| Brain Mapping | 12 | 2011 | 182 | 0.400 |
Why?
|
| Memory, Short-Term | 5 | 2017 | 60 | 0.380 |
Why?
|
| Automation | 2 | 2010 | 30 | 0.370 |
Why?
|
| Middle Aged | 32 | 2018 | 10892 | 0.370 |
Why?
|
| Athletes | 6 | 2020 | 65 | 0.360 |
Why?
|
| Head Protective Devices | 6 | 2015 | 47 | 0.350 |
Why?
|
| Reaction Time | 10 | 2016 | 121 | 0.340 |
Why?
|
| Verbal Behavior | 2 | 2008 | 9 | 0.340 |
Why?
|
| Judgment | 1 | 2007 | 11 | 0.310 |
Why?
|
| Evaluation Studies as Topic | 1 | 2007 | 39 | 0.310 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2018 | 113 | 0.310 |
Why?
|
| Reproducibility of Results | 10 | 2016 | 727 | 0.310 |
Why?
|
| Septum Pellucidum | 1 | 2007 | 2 | 0.300 |
Why?
|
| Psychomotor Performance | 5 | 2016 | 97 | 0.290 |
Why?
|
| Head | 3 | 2022 | 47 | 0.280 |
Why?
|
| Methylphenidate | 2 | 2016 | 36 | 0.270 |
Why?
|
| Parietal Lobe | 4 | 2006 | 16 | 0.260 |
Why?
|
| Students | 4 | 2016 | 170 | 0.250 |
Why?
|
| Attention | 9 | 2016 | 84 | 0.250 |
Why?
|
| Functional Laterality | 7 | 2010 | 59 | 0.250 |
Why?
|
| Amygdala | 3 | 2015 | 60 | 0.250 |
Why?
|
| Borderline Personality Disorder | 1 | 2004 | 3 | 0.240 |
Why?
|
| Aged | 19 | 2012 | 9528 | 0.240 |
Why?
|
| Hypothyroidism | 1 | 2003 | 12 | 0.230 |
Why?
|
| Psychotic Disorders | 3 | 2011 | 10 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2016 | 1079 | 0.230 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2015 | 31 | 0.230 |
Why?
|
| Executive Function | 3 | 2016 | 54 | 0.230 |
Why?
|
| Depressive Disorder | 1 | 2003 | 74 | 0.230 |
Why?
|
| Football | 5 | 2020 | 73 | 0.220 |
Why?
|
| Thalamus | 4 | 2015 | 39 | 0.220 |
Why?
|
| Severity of Illness Index | 8 | 2016 | 864 | 0.210 |
Why?
|
| Corpus Callosum | 3 | 2011 | 13 | 0.200 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 5 | 2011 | 25 | 0.190 |
Why?
|
| Dementia | 1 | 2003 | 234 | 0.190 |
Why?
|
| Models, Biological | 2 | 2014 | 373 | 0.190 |
Why?
|
| Emotions | 2 | 2017 | 48 | 0.180 |
Why?
|
| Accidents, Traffic | 1 | 2022 | 191 | 0.180 |
Why?
|
| Models, Neurological | 3 | 2018 | 115 | 0.180 |
Why?
|
| Acceleration | 5 | 2022 | 60 | 0.180 |
Why?
|
| Post-Concussion Syndrome | 1 | 2018 | 1 | 0.170 |
Why?
|
| Veterans | 2 | 2016 | 50 | 0.170 |
Why?
|
| Universities | 3 | 2015 | 144 | 0.160 |
Why?
|
| Aggression | 2 | 2015 | 29 | 0.160 |
Why?
|
| Temporal Lobe | 6 | 2003 | 41 | 0.160 |
Why?
|
| Health Surveys | 1 | 2018 | 191 | 0.160 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 2117 | 0.160 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2017 | 5 | 0.150 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2013 | 8 | 0.150 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 36 | 0.150 |
Why?
|
| Disease Progression | 3 | 2010 | 572 | 0.150 |
Why?
|
| Analysis of Variance | 7 | 2012 | 454 | 0.150 |
Why?
|
| Comorbidity | 4 | 2018 | 546 | 0.140 |
Why?
|
| Malingering | 1 | 2016 | 5 | 0.140 |
Why?
|
| Case-Control Studies | 7 | 2008 | 862 | 0.140 |
Why?
|
| Epilepsies, Partial | 1 | 2016 | 9 | 0.140 |
Why?
|
| Cohort Studies | 4 | 2020 | 1697 | 0.140 |
Why?
|
| alpha-Synuclein | 1 | 2016 | 10 | 0.140 |
Why?
|
| Aging | 4 | 2007 | 883 | 0.140 |
Why?
|
| Afghan Campaign 2001- | 1 | 2016 | 12 | 0.140 |
Why?
|
| Health Status | 1 | 2018 | 370 | 0.140 |
Why?
|
| Subtraction Technique | 1 | 2016 | 12 | 0.140 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2008 | 80 | 0.140 |
Why?
|
| Apolipoproteins E | 2 | 2006 | 97 | 0.140 |
Why?
|
| Algorithms | 2 | 2016 | 467 | 0.140 |
Why?
|
| Social Behavior | 1 | 2016 | 67 | 0.140 |
Why?
|
| Galantamine | 1 | 2015 | 1 | 0.140 |
Why?
|
| Central Nervous System Stimulants | 1 | 2016 | 74 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 95 | 0.140 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 82 | 0.130 |
Why?
|
| Neostriatum | 1 | 2015 | 21 | 0.130 |
Why?
|
| Brain Injury, Chronic | 1 | 2015 | 1 | 0.130 |
Why?
|
| Obsessive-Compulsive Disorder | 2 | 2007 | 8 | 0.130 |
Why?
|
| Diffuse Axonal Injury | 1 | 2015 | 3 | 0.130 |
Why?
|
| Brain Diseases | 2 | 2010 | 40 | 0.130 |
Why?
|
| Policy Making | 1 | 2015 | 19 | 0.130 |
Why?
|
| Health Priorities | 1 | 2015 | 14 | 0.130 |
Why?
|
| Violence | 1 | 2015 | 14 | 0.130 |
Why?
|
| Recovery of Function | 2 | 2016 | 190 | 0.130 |
Why?
|
| Verbal Learning | 3 | 2006 | 8 | 0.130 |
Why?
|
| Safety | 1 | 2015 | 73 | 0.130 |
Why?
|
| Statistics as Topic | 3 | 2010 | 107 | 0.120 |
Why?
|
| Stress, Psychological | 1 | 2016 | 210 | 0.120 |
Why?
|
| Linkage Disequilibrium | 3 | 2012 | 192 | 0.120 |
Why?
|
| Suicide | 1 | 2014 | 17 | 0.120 |
Why?
|
| Linear Models | 2 | 2016 | 427 | 0.120 |
Why?
|
| Semantics | 3 | 2004 | 11 | 0.120 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2013 | 2 | 0.120 |
Why?
|
| Vocabulary | 3 | 2004 | 3 | 0.110 |
Why?
|
| Software | 3 | 2010 | 110 | 0.110 |
Why?
|
| Dopamine Agonists | 2 | 2011 | 28 | 0.110 |
Why?
|
| Contrast Sensitivity | 1 | 2012 | 3 | 0.110 |
Why?
|
| Electric Stimulation Therapy | 2 | 2003 | 18 | 0.110 |
Why?
|
| Vision Disorders | 1 | 2012 | 20 | 0.110 |
Why?
|
| Double-Blind Method | 4 | 2016 | 504 | 0.110 |
Why?
|
| Mental Recall | 3 | 2001 | 52 | 0.110 |
Why?
|
| Time Factors | 3 | 2015 | 2009 | 0.100 |
Why?
|
| Multiple Sclerosis | 2 | 2003 | 43 | 0.100 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2012 | 36 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 129 | 0.100 |
Why?
|
| Guanfacine | 1 | 2011 | 4 | 0.100 |
Why?
|
| Learning | 1 | 2012 | 76 | 0.100 |
Why?
|
| Parkinson Disease | 2 | 2002 | 68 | 0.100 |
Why?
|
| Language | 2 | 2003 | 44 | 0.100 |
Why?
|
| Bromocriptine | 1 | 2011 | 1 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2010 | 130 | 0.100 |
Why?
|
| Emotional Intelligence | 1 | 2010 | 1 | 0.100 |
Why?
|
| Cerebral Cortex | 4 | 2005 | 141 | 0.090 |
Why?
|
| Obsessive Behavior | 1 | 2010 | 3 | 0.090 |
Why?
|
| Compulsive Behavior | 1 | 2010 | 4 | 0.090 |
Why?
|
| Brain Stem | 1 | 2010 | 18 | 0.090 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2010 | 46 | 0.090 |
Why?
|
| Illness Behavior | 1 | 2009 | 2 | 0.090 |
Why?
|
| Genotype | 4 | 2016 | 735 | 0.090 |
Why?
|
| Organ Size | 1 | 2010 | 196 | 0.090 |
Why?
|
| Antipsychotic Agents | 3 | 2007 | 26 | 0.090 |
Why?
|
| Risk Factors | 5 | 2014 | 3560 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2007 | 3729 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 533 | 0.080 |
Why?
|
| Language Tests | 1 | 2008 | 4 | 0.080 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2008 | 44 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2013 | 672 | 0.080 |
Why?
|
| Prevalence | 2 | 2012 | 908 | 0.080 |
Why?
|
| Quality of Life | 3 | 2018 | 824 | 0.080 |
Why?
|
| Exploratory Behavior | 1 | 2007 | 30 | 0.080 |
Why?
|
| Depression | 3 | 2016 | 386 | 0.080 |
Why?
|
| Reference Values | 5 | 2007 | 224 | 0.080 |
Why?
|
| Hospitalization | 2 | 2004 | 418 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2007 | 16 | 0.080 |
Why?
|
| Anisotropy | 2 | 2020 | 10 | 0.070 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2006 | 14 | 0.070 |
Why?
|
| Atrophy | 4 | 2011 | 51 | 0.070 |
Why?
|
| Fornix, Brain | 1 | 2006 | 7 | 0.070 |
Why?
|
| Bipolar Disorder | 1 | 2006 | 15 | 0.070 |
Why?
|
| Diagnosis, Differential | 4 | 2012 | 493 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2016 | 3116 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2006 | 838 | 0.070 |
Why?
|
| Pseudobulbar Palsy | 1 | 2005 | 5 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2005 | 19 | 0.070 |
Why?
|
| Feeding Behavior | 1 | 1986 | 159 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2004 | 12 | 0.060 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2004 | 29 | 0.060 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2004 | 6 | 0.060 |
Why?
|
| Indans | 1 | 2004 | 25 | 0.060 |
Why?
|
| Prospective Studies | 5 | 2013 | 2035 | 0.060 |
Why?
|
| Thyroid Function Tests | 1 | 2003 | 4 | 0.060 |
Why?
|
| Thyroxine | 1 | 2003 | 16 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 1 | 2003 | 24 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2004 | 28 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 1371 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2003 | 34 | 0.060 |
Why?
|
| Affect | 1 | 2004 | 64 | 0.060 |
Why?
|
| Piperidines | 1 | 2004 | 125 | 0.060 |
Why?
|
| Sex Factors | 3 | 2015 | 632 | 0.060 |
Why?
|
| Neurons | 1 | 2006 | 394 | 0.060 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 725 | 0.060 |
Why?
|
| Huntington Disease | 1 | 2002 | 14 | 0.050 |
Why?
|
| Incidence | 1 | 2006 | 1123 | 0.050 |
Why?
|
| Dominance, Cerebral | 2 | 2007 | 11 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2004 | 871 | 0.050 |
Why?
|
| Child | 3 | 2015 | 2226 | 0.050 |
Why?
|
| Essential Tremor | 1 | 2001 | 13 | 0.050 |
Why?
|
| Alleles | 2 | 2016 | 251 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 299 | 0.050 |
Why?
|
| Proactive Inhibition | 1 | 2001 | 1 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 401 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2001 | 88 | 0.050 |
Why?
|
| Task Performance and Analysis | 3 | 2007 | 51 | 0.050 |
Why?
|
| Oxygen | 2 | 2011 | 139 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2016 | 3129 | 0.050 |
Why?
|
| Observer Variation | 2 | 2012 | 96 | 0.040 |
Why?
|
| Trauma Severity Indices | 2 | 2011 | 51 | 0.040 |
Why?
|
| Personality Inventory | 2 | 2009 | 18 | 0.040 |
Why?
|
| Syndrome | 2 | 2010 | 66 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2008 | 225 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2018 | 211 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 293 | 0.040 |
Why?
|
| Neural Pathways | 2 | 2007 | 97 | 0.040 |
Why?
|
| Apolipoprotein E4 | 2 | 2006 | 58 | 0.040 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 42 | 0.040 |
Why?
|
| Basal Ganglia | 1 | 1996 | 15 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 1996 | 28 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2016 | 71 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2016 | 25 | 0.030 |
Why?
|
| Discrimination Learning | 1 | 1996 | 20 | 0.030 |
Why?
|
| Brief Psychiatric Rating Scale | 2 | 2007 | 3 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2016 | 70 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 167 | 0.030 |
Why?
|
| Affective Symptoms | 1 | 2015 | 16 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 213 | 0.030 |
Why?
|
| Minnesota | 1 | 2015 | 18 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 525 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 37 | 0.030 |
Why?
|
| United States | 2 | 2014 | 3655 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 223 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 156 | 0.030 |
Why?
|
| Skiing | 1 | 2013 | 2 | 0.030 |
Why?
|
| Track and Field | 1 | 2013 | 3 | 0.030 |
Why?
|
| Mental Health Services | 1 | 2014 | 24 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 483 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2014 | 49 | 0.030 |
Why?
|
| Medical Records | 1 | 2014 | 68 | 0.030 |
Why?
|
| Paranoid Disorders | 1 | 2013 | 1 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 208 | 0.030 |
Why?
|
| Prefrontal Cortex | 2 | 2006 | 69 | 0.030 |
Why?
|
| Sleep Stages | 1 | 2012 | 6 | 0.030 |
Why?
|
| Unconsciousness | 1 | 2012 | 5 | 0.030 |
Why?
|
| Dizziness | 1 | 2012 | 11 | 0.030 |
Why?
|
| Neck Pain | 1 | 2012 | 6 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2013 | 63 | 0.030 |
Why?
|
| Intelligence | 2 | 2004 | 5 | 0.030 |
Why?
|
| Headache | 1 | 2012 | 74 | 0.030 |
Why?
|
| New Hampshire | 1 | 2011 | 5 | 0.030 |
Why?
|
| Sports Equipment | 1 | 2011 | 4 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2012 | 69 | 0.030 |
Why?
|
| Sports | 1 | 2012 | 33 | 0.030 |
Why?
|
| Acute Disease | 1 | 2012 | 239 | 0.030 |
Why?
|
| Telemetry | 1 | 2011 | 27 | 0.030 |
Why?
|
| Rotation | 1 | 2011 | 46 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 1115 | 0.030 |
Why?
|
| Speech Perception | 2 | 2001 | 6 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2004 | 274 | 0.030 |
Why?
|
| Prolactin | 1 | 2011 | 10 | 0.020 |
Why?
|
| Schools | 1 | 2011 | 65 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2011 | 80 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2011 | 95 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2010 | 33 | 0.020 |
Why?
|
| Cranial Nerve Diseases | 1 | 2010 | 5 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 129 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 1991 | 167 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2009 | 9 | 0.020 |
Why?
|
| Self Concept | 1 | 2009 | 42 | 0.020 |
Why?
|
| DNA Replication | 1 | 2008 | 25 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 631 | 0.020 |
Why?
|
| Haplotypes | 1 | 2008 | 220 | 0.020 |
Why?
|
| Behavioral Symptoms | 1 | 2007 | 3 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2007 | 27 | 0.020 |
Why?
|
| Cephalometry | 1 | 2007 | 18 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 729 | 0.020 |
Why?
|
| Receptors, Catecholamine | 1 | 2006 | 1 | 0.020 |
Why?
|
| Apolipoprotein E3 | 1 | 2006 | 3 | 0.020 |
Why?
|
| Drinking Behavior | 1 | 1986 | 10 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 792 | 0.020 |
Why?
|
| Catecholamines | 1 | 2006 | 17 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 67 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 104 | 0.020 |
Why?
|
| Reinforcement Schedule | 1 | 1986 | 60 | 0.020 |
Why?
|
| Eating | 1 | 1986 | 73 | 0.020 |
Why?
|
| Conditioning, Operant | 1 | 1986 | 96 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2005 | 27 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2004 | 2 | 0.020 |
Why?
|
| Mutation | 1 | 2006 | 469 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2004 | 41 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 196 | 0.010 |
Why?
|
| Social Support | 1 | 2004 | 165 | 0.010 |
Why?
|
| Mass Screening | 1 | 2005 | 226 | 0.010 |
Why?
|
| Gyrus Cinguli | 1 | 2003 | 22 | 0.010 |
Why?
|
| Anxiety | 1 | 2004 | 160 | 0.010 |
Why?
|
| Rats | 1 | 1986 | 1607 | 0.010 |
Why?
|
| Serial Learning | 1 | 2001 | 2 | 0.010 |
Why?
|
| Pattern Recognition, Visual | 1 | 2001 | 12 | 0.010 |
Why?
|
| Subthalamic Nucleus | 1 | 2001 | 14 | 0.010 |
Why?
|
| Time Perception | 1 | 2001 | 6 | 0.010 |
Why?
|
| Schizophrenia, Disorganized | 1 | 2000 | 1 | 0.010 |
Why?
|
| Schizophrenia, Paranoid | 1 | 2000 | 2 | 0.010 |
Why?
|
| Echo-Planar Imaging | 1 | 1999 | 16 | 0.010 |
Why?
|
| Phonetics | 1 | 1999 | 2 | 0.010 |
Why?
|
| Auditory Perception | 1 | 1999 | 80 | 0.010 |
Why?
|
| Mathematics | 1 | 1998 | 9 | 0.010 |
Why?
|
| Neoplasms | 1 | 2004 | 620 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1998 | 141 | 0.010 |
Why?
|
| Oxygen Radioisotopes | 1 | 1996 | 1 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1996 | 7 | 0.010 |
Why?
|
| Medical Illustration | 1 | 1996 | 7 | 0.010 |
Why?
|
| Anatomy, Artistic | 1 | 1996 | 3 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1996 | 25 | 0.010 |
Why?
|
| Cerebellum | 1 | 1996 | 29 | 0.010 |
Why?
|
| Benztropine | 1 | 1994 | 3 | 0.010 |
Why?
|
| Age of Onset | 1 | 1994 | 95 | 0.010 |
Why?
|
| Animals | 1 | 1986 | 7318 | 0.010 |
Why?
|
| Patient Admission | 1 | 1994 | 53 | 0.010 |
Why?
|